Back to Protocols & Dosing
Protocols & Dosing10 min read

CJC-1295 Reconstitution and Dosing: DAC Versus No-DAC in the Literature

Educational review of CJC-1295 with and without DAC: half-life differences from published GH studies, lyophilized-vial math, and research-reference ranges versus community secretagogue tables.

PeptIQ Team
Peptide Research & Education
CJC-1295 Reconstitution and Dosing: DAC Versus No-DAC in the Literature

PeptIQ app

Calculate your CJC-1295 reconstitution in PeptIQ

Stop guessing syringe math. Log vials, BAC water, and doses — then track every injection free.

Get the app — freeOpen free web app

Free · iOS, Android, and web

Ask PeptIQ

Two taps on our guided quiz, then keep going in iMessage with sources — not Instagram screenshots.

Start the quizOr try Peptide X Quiz →

Explore providers

Telehealth assessments for compounds mentioned on this page. PeptIQ may earn a referral fee. Not medical advice.

Module 2 — Metabolic & GH-axis peptides

Lesson 12 of 17 in Peptide deep dives

  • Map GLP-1 mechanisms to expectations
  • Compare secretagogue approaches
Up next: Ipamorelin reconstitution and dosing

# CJC-1295 Reconstitution and Dosing: DAC Versus No-DAC in the Literature

> Note: PeptIQ is not a medical provider. This article is educational only. Published figures and community logs are not a protocol.

CJC-1295 is a tetrasubstituted analog of growth hormone-releasing hormone (GHRH). The version with a Drug Affinity Complex (DAC) can bind albumin and stay in circulation for days. The version without DAC, often sold as Mod GRF 1-29, is discussed as a short pulse measured in minutes. Teichman and colleagues reported prolonged GH and IGF-1 stimulation after a single administration of CJC-1295 (PubMed 16352683). ClinicalTrials.gov indexes related GH studies (search).

A reconstitution conversation that does not name DAC versus no-DAC is incomplete. The same milligram label can imply weekly or multiple-daily exposure depending on the analog.

Evidence tier

LayerWhat it showsWhat it does not
Teichman 2006 and related GH papersMulti-day GH/IGF-1 elevation after DAC-form exposure in study volunteersA consumer vial schedule
GHRH plus GHRP synergy papersPharmacologic rationale for pairing a GHRH analog with a secretagogueProof that a specific stack is indicated
Community tablesMicrogram bands and pin frequency by DAC statusSafety or efficacy

Bowers and colleagues described synergistic GH release when GHRH and a GH-releasing peptide were combined in men (PubMed 2108187). Synergy in a study is not a mixing instruction.

Lyophilized-vial math

Educational write-ups use the same concentration formula as other freeze-dried peptides:

Concentration (mcg/mL) = (vial mg × 1,000) ÷ diluent mL

Volume (mL) = desired mcg ÷ concentration

Illustrative examples only

A vial labeled 2 mg with 2 mL bacteriostatic water is 1,000 mcg/mL. A 100 mcg discussion figure would be 0.10 mL (10 units on a U-100 syringe). A 5 mg vial with 2 mL is 2,500 mcg/mL, so 100 mcg is 0.04 mL (4 units), which is a small draw and easy to misread.

Those examples exist to show why vial size and water volume dominate the syringe reading. They are not a recommended reconstitution.

Bacteriostatic water is the diluent named most often for multi-draw research vials. Cold, dark storage for the dry cake and refrigeration after reconstitution are the usual handling claims. Beyond-use dating on unlabeled vials is not standardized.

Research-reference ranges

Teichman's CJC-1295 study used microgram-per-kilogram single doses in a clinical research setting, then followed GH and IGF-1 for days. That is a pharmacokinetic experiment. It is not a weekly 2 mg community habit dressed up as a trial arm.

Community education usually splits:

Analog people think they haveCadence they discussHow to read it
With DACLess frequent, often weekly narrativesMatches long half-life story, not a label
No DAC / Mod GRF 1-29Same sitting as a GHRP, more frequentMatches short pulse story, not a label

PeptIQ users who log CJC-1295 often pair it with ipamorelin in the same session. That is a logging correlation. It is not a finding that the pair is indicated.

Typical community microgram bands for the no-DAC analog sit in the low hundreds of micrograms per administration. DAC-form community tables more often use milligrams less often. Both are uncontrolled conventions. Published mg/kg study doses do not automatically equal those tables.

Route language

Study papers and community education both talk about subcutaneous administration for these analogs. That is a route description. It is not an injection walkthrough. Secretagogues are often described as more fragile in mixed syringes than simpler repair peptides. Separate draws remove a chemistry unknown. That is a risk comment, not a technique lesson.

For analog differences without the math, see the DAC versus no-DAC comparison guide and the CJC-1295 plus ipamorelin stack explainer.

Bottom line

Name the analog first. DAC and no-DAC are different exposure patterns in the literature. Reconstitution arithmetic is generic. Dose calendars on forums are not Teichman 2006. Educational use only.

Share this article

Track Your Peptide Protocols

Use PeptIQ to log injections, calculate doses, access our peptide library, and optimize your protocols.

Stay ahead of the peptide conversation

Weekly-ish notes on new research, wiki trends, and practical tracking tips. No spam — unsubscribe anytime.

Educational updates only — not medical advice. Privacy